References
- Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E. and Forman, D. (2011) Global cancer statistics. CA Cancer J. Clin., 61, 69-90. https://doi.org/10.3322/caac.20107
- Cook, M.B., McGlynn, K.A., Devesa, S.S., Freedman, N.D. and Anderson, W.F. (2011) Sex disparities in cancer mortality and survival. Cancer Epidemiol. Biomarkers Prev., 20, 1629-1637. https://doi.org/10.1158/1055-9965.EPI-11-0246
- Siegel, R.L., Miller, K.D. and Jemal, A. (2016) Cancer statistics. CA Cancer J. Clin., 66, 7-30. https://doi.org/10.3322/caac.21332
- Fitzmaurice, C., Allen, C., Barber, R.M., Barregard, L., Bhutta, Z.A., Brenner, H., Dicker, D.J., Chimed-Orchir, O., Dandona, R., Dandona, L., Fleming, T., Forouzanfar, M.H., Hancock, J., Hay, R.J., Hunter-Merrill, R., Huynh, C., Hosgood, H.D., Johnson, C.O., Jonas, J.B., Khubchandani, J., Kumar, G.A., Kutz, M., Lan, Q., Larson, H.J., Liang, X., Lim, S.S., Lopez, A.D., MacIntyre, M.F., Marczak, L., Marquez, N., Mokdad, A.H., Pinho, C., Pourmalek, F., Salomon, J.A., Sanabria, J.R., Sandar, L., Sartorius, B., Schwartz, S.M., Shackelford, K.A., Shibuya, K., Stanaway, J., Steiner, C., Sun, J., Takahashi, K., Vollset, S.E., Vos, T., Wagner, J.A., Wang, H., Westerman, R., Zeeb, H., Zoeckler, L., Abd-Allah, F., Ahmed, M.B., Alabed, S., Alam, N.K., Aldhahri, S.F., Alem, G., Alemayohu, M.A., Ali, R., Al-Raddadi, R., Amare, A., Amoako, Y., Artaman, A., Asayesh, H., Atnafu, N., Awasthi, A., Saleem, H.B., Barac, A., Bedi, N., Bensenor, I., Berhane, A., Bernabe, E., Betsu, B., Binagwaho, A., Boneya, D., Campos-Nonato, I., Castaneda-Orjula, C., Catala-Lopez, F., Chiang, P., Chibueze, C., Chitheer, A., Choi, J.Y., Cowie, B., Damtew, S., das, N.J., Dey, S., Dharmaratne, S., Dhillon, P., Ding, E., Driscoll, T., Ekwueme, D., Endries, A.Y., Farvid, M., Farzadfar, F., Fernandes, J., Fischer, F., G/Hiwot, T.T., Gebru, A., Gopalani, S., Hailu, A., Horino, M., Horita, N., Husseini, A., Huybrechts, I., Inoue, M., Islami, F., Jakovljevic, M., James, S., Javanbakht, M., Jee, S.H., Kasaeian, A., Kedir, M.S., Khader, Y.S., Khang, Y.H., Kim, D., Leigh, J., Linn, S., Lunevicius, R., El Razek, H.M.A., Malekzadeh, R., Malta, D.C., Marcenes, W., Markos, D., Melaku, Y.A., Meles, K.G., Mendoza, W., Mengiste, D.T., Meretoja, T.J., Miller, T.R., Mohammad, K.A., Mohammadi, A., Mohammed, S., Moradi-Lakeh, M., Nagel, G., Nand, D., Le Nguyen, Q., Nolte, S., Ogbo, F.A., Oladimeji, K.E., Oren, E., Pa, M., Park, E.K., Pereira, D.M., Plass, D., Qorbani, M., Radfar, A., Rafay, A., Rahman, M., Rana, S.M., Soreide, K., Satpathy, M., Sawhney, M., Sepanlou, S.G., Shaikh, M.A., She, J., Shiue, I., Shore, H.R., Shrime, M.G., So, S., Soneji, S., Stathopoulou, V., Stroumpoulis, K., Sufiyan, M.B., Sykes, B.L., Tabares-Seisdedos, R., Tadese, F., Tedla, B.A., Tessema, G.A., Thakur, J.S., Tran, B.X., Ukwaja, K.N., Uzochukwu, B.S.C., Vlassov, V.V., Weiderpass, E., Wubshet, T.M., Yebyo, H.G., Yimam, H.H., Yonemoto, N., Younis, M.Z., Yu, C., Zaidi, Z., Zaki, M.E.S., Zenebe, Z.M., Murray, C.J.L. and Naghavi, M. (2017) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol., 3, 524-548. https://doi.org/10.1001/jamaoncol.2016.5688
- Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre. L.A. and Jemal, A. (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 68, 394-424. https://doi.org/10.3322/caac.21492
- Hefaiedh, R., Ennaifer, R., Romdhane, H., Ben, N.H., Arfa, N., Belhadj, N., Gharbi, L. and Khalfallah, T. (2013) Gender difference in patients with hepatocellular carcinoma. Tunis Med., 91, 505-508.
- Dobruch, J., Daneshmand, S., Fisch, M., Lotan, Y., Noon, A.P., Resnick, M.J., Shariat, S.F., Zlotta, A.R. and Boorjian, S.A. (2016) Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes. Eur. Urol., 69, 300-310. https://doi.org/10.1016/j.eururo.2015.08.037
- Horstmann, M., Witthuhn, R., Falk, M. and Stenzl, A. (2008) Gender-specific differences in bladder cancer: a retrospective analysis. Gend. Med., 5, 385-394. https://doi.org/10.1016/j.genm.2008.11.002
- Shariat, S.F., Sfakianos, J.P., Droller, M.J., Karakiewicz, P.I., Meryn, S. and Bochner, B.H.. (2010) The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int., 105, 300-308. https://doi.org/10.1111/j.1464-410X.2009.09076.x
- Jung, K.W., Won, Y.J., Kong, H.J., Oh, C.M., Cho, H., Lee, D.H. and Lee, K.H. (2015) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res. Treat., 47, 127-141. https://doi.org/10.4143/crt.2015.060
- Matsuda, A., Matsuda, T., Shibata, A., Katanoda, K., Sobue, T. and Nishimoto, H. (2008) Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn. J. Clin. Oncol., 44, 388-396.
- Ferlay, J., Ervik, M., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D. and Bray, F. (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer, 136, 359-386. https://doi.org/10.1002/ijc.29210
- Stafford, H.S., Saltzstein, S.L., Shimasaki, S., Sanders, C., Downs, T.M. and Sadler, G.R. (2008) Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival. J. Urol., 179, 1704-1708. https://doi.org/10.1016/j.juro.2008.01.027
- Roberts, J.C., Li, G., Reitzel, L.R., Wei, Q. and Sturgis, E.M. (2010) No evidence of sex-related survival disparities among head and neck cancer patients receiving similar multidisciplinary care: a matched-pair analysis. Clin. Cancer Res., 16, 5019-5027. https://doi.org/10.1158/1078-0432.CCR-10-0755
- Ozdemir, B.C. and Dotto, G.P. (2019) Sex hormones and anticancer immunity. Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-19-0137 [Epub ahead of print].
- Kim, H.I., Lim, H. and Moon, A. (2018) Sex differences in cancer: epidemiology, genetics and therapy. Biomol. Ther. (Seoul), 26, 335-342. https://doi.org/10.4062/biomolther.2018.103
- Cui, C., Yang, W., Shi, J., Zhou, Y., Yang, J., Cui, Q. and Zhou, Y. (2018) Identification and analysis of human sex-biased microRNAs. Genomics Proteomics Bioinformatics, 16, 200-211. https://doi.org/10.1016/j.gpb.2018.03.004
- Yuan, Y., Liu, L., Chen, H., Wang, Y., Xu, Y., Mao, H., Li, J., Mills, G.B., Shu, Y., Li, L. and Liang, H. (2016) Comprehensive characterization of molecular differences in cancer between male and female patients. Cancer Cell., 29, 711-722. https://doi.org/10.1016/j.ccell.2016.04.001
- Ellegren, H. and Parsch, J. (2007) The evolution of sexbiased genes and sex-biased gene expression. Nat. Rev. Genet., 8, 689-698. https://doi.org/10.1038/nrg2167
- Milano, G., Etienne, M.C., Cassuto-Viguier, E., Thyss, A., Santini, J., Frenay, M., Renee, N., Schneider, M. and Demard, F. (1992) Influence of sex and age on fluorouracil clearance. J. Clin. Oncol., 10, 1171-1175. https://doi.org/10.1200/JCO.1992.10.7.1171
- Sloan, J.A., Goldberg, R.M., Sargent, D.J., Vargas-Chanes, D., Nair, S., Cha, S.S., Novotny, P.J., Poon, M.A., O'Connell, M.J. and Loprinzi, C.L. (2002) Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. J. Clin. Oncol., 20, 1491-1498. https://doi.org/10.1200/JCO.2002.20.6.1491
- Lim, H., Kim, S.Y., Lee, E., Lee, S., Oh, S., Jung, J., Kim, K.S. and Moon, A. (2019) Sex-dependent adverse drug reactions to 5-fluorouracil in colorectal cancer. Biol. Pharm. Bull., 42, 594-600. https://doi.org/10.1248/bpb.b18-00707
- Giudicelli, J.F. and Tillement, J.P. (1977) Influence of sex on drug kinetics in man. Clin. Pharmacokinet., 2, 157-166. https://doi.org/10.2165/00003088-197702030-00001
- Wilson, K. (1984) Sex-related differences in drug disposition in man. Clin. Pharmacokinet., 9, 189-202. https://doi.org/10.2165/00003088-198409030-00001
- Bonate, P.L. (1991) Gender-related differences in xenobiotic metabolism. J. Clin Pharmacol., 31, 684-690. https://doi.org/10.1002/j.1552-4604.1991.tb03760.x
- Harris, J.R., Tambs, K. and Magnus, P. (1995) Sex-specific effects for body mass index in the new Norwegian twin panel. Genet. Epidemiol., 12, 251-265. https://doi.org/10.1002/gepi.1370120303
- Xie, Y., Miller, G.G., Cubitt, S.A., Soderlind, K.J., Allalunis-Turner, M.J. and Lown, J.W. (1997) Enediyne-lexitrop-sinDNA-targeted anticancer agents. Physicochemical and cytotoxic properties in human neoplastic cells in vitro, and intracellular distribution. Anticancer Drug Des., 12, 169-179.
- Dorak, M.T. and Karpuzoglu, E. (2012) Gender differences in cancer susceptibility: an inadequately addressed issue. Front. Genet., 3, 268-276. https://doi.org/10.3389/fgene.2012.00268
- Xiao, D., Pan, H., Li, F., Wu, K., Zhang, X. and He, J. (2016) Analysis of ultra-deep targeted sequencing reveals mutation burden is associated with gender and clinical outcome in lung adenocarcinoma. Oncotarget, 7, 22857-22864. https://doi.org/10.18632/oncotarget.8213
- Baak, J.P., Path, F.R., Hermsen, M.A., Meijer, G., Schmidt, J. and Janssen, E.A. (2003) Genomics and proteomics in cancer. Eur. J. Cancer, 39, 1199-1215. https://doi.org/10.1016/S0959-8049(03)00265-X
- Parkin, D.M. (2008) The global burden of urinary bladder cancer. Scand. J. Urol. Nephrol. Suppl., 218, 12-20. https://doi.org/10.1080/03008880802285032
- American Cancer Society (2009) Cancer Facts & Figures 2009, American Cancer Society, Atlanta, pp. 1-5.
- Wilhelm, C.S., Kelsey, K.T., Butler, R., Plaza, S., Gagne, L., Zens, M.S., Andrew, A.S., Morris, S., Nelson, H.H., Schned, A.R., Karagas, M.R. and Marsit, C.J. (2010) Implications of LINE1 methylation for bladder cancer risk in women. Clin. Cancer Res., 16, 1682-1689. https://doi.org/10.1158/1078-0432.CCR-09-2983
- Valdes-Mora, F., Gomez del, P.T., Bandres, E., Cejas, P., Ramirez de Molina, A., Perez-Palacios, R., Gallego-Ortega, D., Garcia-Cabezas, M.A., Casado, E., Larrauri, J., Nistal, M., Gonzalez-Baron, M., Garcia-Foncillas, J. and Lacal, J.C. (2009) TWIST1 overexpression is associated with nodal invasion and male sex in primary colorectal cancer. Ann. Surg. Oncol., 16, 78-87. https://doi.org/10.1245/s10434-008-0166-x
- Van der Auwera, I., Bovie, C., Svensson, C., Trinh, X.B., Limame, R., van Dam, P., van Laere, S.J., van Marck, E.A., Dirix, L.Y. and Vermeulen, P.B. (2010) Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients. BMC Cancer, 10, 97. https://doi.org/10.1186/1471-2407-10-97
- Sasaki, K., Natsugoe, S., Ishigami, S., Matsumoto, M., Okumura, H., Setoyama, T., Uchikado, Y., Kita, Y., Tamotsu, K., Sakamoto, A., Owaki, T. and Aikou, T. (2009) Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma. J. Exp. Clin. Cancer Res., 28, 158. https://doi.org/10.1186/1756-9966-28-158
- Mikheeva, S.A., Mikheev, A.M., Petit, A., Beyer, R., Oxford, R.G., Khorasani, L., Maxwell, J.P., Glackin, C.A., Wakimoto, H., Gonzalez-Herrero, I., Sanchez-Garcia, I., Silber, J.R., Horner, P.J. and Rostomily, R.C. (2010) TWIST1 promotes invasion through mesenchymal change in human glioblastoma. Mol. Cancer, 9, 194. https://doi.org/10.1186/1476-4598-9-194
- De Roock, W., Piessevaux, H., De Schutter, J., Janssens, M., De Hertogh, G., Personeni, N., Biesmans, B., Van Laethem, J.L., Peeters, M., Humblet, Y., Van Cutsem, E. and Tejpar, S. (2008) KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab. Ann. Oncol., 19, 508-515. https://doi.org/10.1093/annonc/mdm496
- Lievre, A., Bachet, J.B., Le Corre, D., Boige, V., Landi, B., Emile, J.F., Cote, J.F., Tomasic, G., Penna, C., Ducreux, M., Rougier, P., Penault-Llorca, F. and Laurent-Puig, P. (2006) KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res., 66, 3992-3995. https://doi.org/10.1158/0008-5472.CAN-06-0191
- Freeman, D.J., Juan, T., Reiner, M., Hecht, J.R., Meropol, N.J., Berlin, J., Mitchell, E., Sarosi, I., Radinsky, R. and Amado, R.G. (2008) Association of K-ras mutational status and clinical outcomes in patients with metastatic colorectal cancer receiving panitumumab alone. Clin. Colorectal Cancer, 7, 184-190. https://doi.org/10.3816/CCC.2008.n.024
- Breivik, J., Meling, G.I., Spurkland, A., Rognum, T.O. and Gaudernack, G. (1994) K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location. Br. J. Cancer, 69, 367-371. https://doi.org/10.1038/bjc.1994.67
- Nussler, N.C., Reinbacher, K., Shanny, N., Schirmeier, A., Glanemann, M., Neuhaus, P., Nussler, A.K. and Kirschner, M. (2008) Sex-specific differences in the expression levels of estrogen receptor subtypes in colorectal cancer. Gend. Med., 5, 209-217. https://doi.org/10.1016/j.genm.2008.07.005
- Campbell-Thompson, M., Lynch, I.J. and Bhardwaj, B. (2001) Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res., 61, 632-640.
-
Wiencke, J.K., Zheng, S., Lafuente, A., Lafuente, M.J., Grudzen, C., Wrensch, M.R., Miike, R., Ballesta, A. and Trias, M. (1999) Aberrant methylation of
$p16^{INK4a}$ in anatomic and gender-specific subtypes of sporadic colorectal cancer. Cancer Epidemiol. Biomarkers Prev., 8, 501-506. - Dehm, S.M. and Bonham, K. (2004) SRC gene expression in human cancer: the role of transcriptional activation. Biochem. Cell Biol., 82, 263-274. https://doi.org/10.1139/o03-077
- Takemoto, N., Iizuka, N., Yamada-Okabe, H., Hamada, K., Tamesa, T., Okada, T., Hashimoto, K., Sakamoto, K., Takashima, M., Miyamoto, T., Uchimura, S., Hamamoto, Y. and Oka, M. (2005) Sex-based molecular profiling of hepatitis C virus-related hepatocellular carcinoma. Int. J. Oncol., 26, 673-678.
- Sun, Q.K., Zhu, J.Y., Wang, W., Lv, Y., Zhou, H.C., Yu, J.H., Xu, G.L., Ma, J.L., Zhong, W. and Jia, W.D. (2014) Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma. Med. Oncol., 31, 786-797. https://doi.org/10.1007/s12032-013-0786-2
- Lehtonen, S.T., Svensk, A.M., Soini, Y., Paakko, P., Hirvikoski, P., Kang, S.W., Saily, M. and Kinnula, V.L. (2004) Peroxiredoxins, a novel protein family in lung cancer. Int. J. Cancer, 111, 514-521. https://doi.org/10.1002/ijc.20294
- Cha, M.K., Suh, K.H. and Kim, I.H. (2009) Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma. J. Exp. Clin. Cancer Res., 28, 93. https://doi.org/10.1186/1756-9966-28-93
- Yang, L., Li, Y., Hong, H., Chang, C.W., Guo, L.W., Lyn-Cook, B., Shi, L. and Ning, B. (2012) Sex differences in the expression of drug-metabolizing and transporter genes in human liver. J. Drug Metab. Toxicol., 3, 1000119.
- Parkinson, A., Mudra, D.R., Johnson, C., Dwyer, A. and Carroll, K.M. (2004) The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol. Appl. Pharmacol., 199, 193-209. https://doi.org/10.1016/j.taap.2004.01.010
- Paris, P.L., Kupelian, P.A., Hall, J.M., Williams, T.L., Levin, H., Klein, E.A., Casey, G. and Witte, J.S. (1999) Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients. Cancer Epidemiol. Biomarkers Prev., 8, 901-905.
- Tanaka, E. (1999) Gender-related differences in pharmacokinetics and their clinical significance. J. Clin. Pharm. Ther., 24, 339-346. https://doi.org/10.1046/j.1365-2710.1999.00246.x
- Scandlyn, M.J., Stuart, E.C. and Rosengren, R.J. (2008) Sex-specific differences in CYP450 isoforms in humans. Expert Opin. Drug Metab. Toxicol., 4, 413-424. https://doi.org/10.1517/17425255.4.4.413
- Ou-Yang, D.S., Huang, S.L., Wang, W., Xie, H.G., Xu, Z.H., Shu, Y. and Zhou, H.H. (2000) Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population. Br. J. Clin. Pharmacol., 49, 145-151. https://doi.org/10.1046/j.1365-2125.2000.00128.x
- Shepherd, F.A., Rodrigues Pereira, J., Ciuleanu, T., Tan, E.H., Hirsh, V., Thongprasert, S., Campos, D., Maoleekoonpiroj, S., Smylie, M., Martins, R., van Kooten, M., Dediu, M., Findlay, B., Tu, D., Johnston, D., Bezjak, A., Clark, G., Santabarbara, P. and Seymour, L.; National Cancer Institute of Canada Clinical Trials Group (2005) Erlotinib in previously treated non-small-cell lung cancer. N. Engl. J. Med., 353, 123-132. https://doi.org/10.1056/NEJMoa050753
- Izbicka, E., Streeper, R.T., Michalek, J.E., Louden, C.L., Diaz, A. 3rd and Campos, D.R. (2012) Plasma biomarkers distinguish non-small cell lung cancer from asthma and differ in men and women. Cancer Genomics Proteomics, 9, 27-35.
- Liao, J. and McCauley, L.K. (2006) Skeletal metastasis: Established and emerging roles of parathyroid hormone related protein (PTHrP). Cancer Metastasis Rev., 25, 559-571. https://doi.org/10.1007/s10555-006-9033-z
- Hastings, R.H., Laux, A.M., Casillas, A., Xu, R., Lukas, Z., Ernstrom, K. and Deftos, L.J. (2006) Sex-specific survival advantage with parathyroid hormone-related protein in non-small cell lung carcinoma patients. Clin. Cancer Res., 12, 499-506. https://doi.org/10.1158/1078-0432.CCR-05-0930
- Parisi, M., Nuttall, R., Naiman, D., Bouffard, G., Malley, J., Andrews, J., Eastman, S. and Oliver, B. (2003) Paucity of genes on the Drosophila X chromosome showing male-biased expression. Science, 299, 697-700. https://doi.org/10.1126/science.1079190
- Ellegren, H. and Parsch, J. (2007) The evolution of sex-biased genes and sex-biased gene expression. Nat. Rev. Genet., 8, 689-698. https://doi.org/10.1038/nrg2167
- Williams, T.M. and Carroll, S.B. (2009) Genetic and molecular insights into the development and evolution of sexual dimorphism. Nat. Rev. Genet., 10, 797-804. https://doi.org/10.1038/nrg2687
- Mank, J.E. and Avise, J.C. (2009) Evolutionary diversity and turn-over of sex determination in teleost fishes. Sex. Dev., 3, 60-67. https://doi.org/10.1159/000223071
- Connallon, T. and Clark, A.G. (2010) Sex linkage, sex-specific selection, and the role of recombination in the evolution of sexually dimorphic gene expression. Evolution, 64, 3417-3442. https://doi.org/10.1111/j.1558-5646.2010.01136.x
- Su, A.I., Cooke, M.P., Ching, K.A., Hakak, Y., Walker, J.R., Wiltshire, T., Orth, A.P., Vega, R.G., Sapinoso, L.M., Moqrich, A., Patapoutian, A., Hampton, G.M., Schultz, P.G. and Hogenesch, J.B. (2002) Large-scale analysis of the human and mouse transcriptomes. Proc. Natl. Acad. Sci. U.S.A., 99, 4465-4470. https://doi.org/10.1073/pnas.012025199
- Rong, Z., Fan, T., Li, H., Li, J., Wang, K., Wang, X., Dong, J., Chen, J., Wang, F., Wang, J. and Wang, A. (2017) Differential proteomic analysis of gender-dependent hepatic tumorigenesis in Hras12V transgenic mice. Mol. Cell. Proteomics, 16, 1475-1490. https://doi.org/10.1074/mcp.M116.065474
- Li, Z., Tuteja, G., Schug, J. and Kaestner, K.H. (2012) Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer. Cell, 148, 72-83. https://doi.org/10.1016/j.cell.2011.11.026
- Liao, Y.J., Liu, S.P., Lee, C.M., Yen, C.H., Chuang, P.C., Chen, C.Y., Tsai, T.F., Huang, S.F., Lee, Y.H. and Chen, Y.M. (2009) Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility. Int. J. Cancer, 124, 816-826. https://doi.org/10.1002/ijc.23979
- Mato, J.M. and Lu, S.C. (2007) Role of S-adenosyl-L-methionine in liver health and injury. Hepatology, 45, 1306-1312. https://doi.org/10.1002/hep.21650
- Cheng, F. (2016) Gender dimorphism creates divergent cancer susceptibilities. Trends Cancer, 2, 325-326. https://doi.org/10.1016/j.trecan.2016.06.001
- Van Nas, A., Guhathakurta, D., Wang, S.S., Yehya, N., Horvath, S., Zhang, B., Ingram-Drake, L., Chaudhuri, G., Schadt, E.E., Drake, T.A., Arnold, A.P. and Lusis, A.J. (2009) Elucidating the role of gonadal hormones in sexually dimorphic gene coexpression networks. Endocrinology, 150, 1235-1249. https://doi.org/10.1210/en.2008-0563
- Mittelstrass, K., Ried, J.S., Yu, Z., Krumsiek, J., Gieger, C., Prehn, C., Roemisch-Margl, W., Polonikov, A., Peters, A., Theis, F.J., Meitinger, T., Kronenberg, F., Weidinger, S., Wichmann, H.E., Suhre, K., Wang-Sattler, R., Adamski, J. and Illig, T. (2011) Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet., 7, e1002215. https://doi.org/10.1371/journal.pgen.1002215